News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Batu Biologics Recruits Renowned Cancer Immunologist To Scientific Advisory Board


7/1/2014 11:16:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics Inc, an immunotherapy company developing ValloVaxTM, the first anti-angiogenic cancer vaccine, announced today the appointment of Boris Minev, M.D. to the company’s Scientific Advisory Board (SAB). Dr. Minev is an internationally renowned key opinion leader in tumor immunology, currently serving as Principal Investigator, Director, Laboratory of Tumor Immunology and Immunotherapy at Moores UCSD Cancer Center, as well as Director of Immunotherapy and Translational Oncology at Genelux Corporation. Dr. Minev will assist Batu Biologics in advancing ValloVaxTM through FDA clinical trials, which are anticipated to begin in early 2015.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES